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Abstract
Background: Internet-based treatments appear to be a promising way to enhance the in vivo exposure approach,
specifically in terms of acceptability and access to treatment. However, the literature on specific phobias is scarce,
and, as far as we know, there are no studies on Flying Phobia (FP). This study aims to investigate the effectiveness
of an Internet-based exposure treatment for FP (NO-FEAR Airlines) that includes exposure scenarios composed of
images and sounds, versus a waiting-list control group. A secondary aim is to explore two ways of delivering NO-
FEAR Airlines, with and without therapist guidance.
Methods: A randomized controlled trial (RCT) was conducted in which 69 participants were allocated to: 1) NO-
FEAR Airlines totally self-applied, 2) NO-FEAR Airlines with therapist guidance, 3) a waiting-list control group. Primary
outcome measures were the Fear of Flying Questionnaire-II and the Fear of Flying Scale. Secondary outcomes
included the Fear and Avoidance Scales, Clinician Severity Scale, and Patient’s Improvement scale. Behavioral outcomes
(post-treatment flights and safety behaviors) were also included. Mixed-model analyses with no ad hoc imputations
were conducted for primary and secondary outcome measures.
Results: NO-FEAR Airlines (with and without therapist guidance) was significantly effective, compared to the waiting
list control group, on all primary and secondary outcomes (all ps < .05), and no significant differences were found
between the two ways of delivering the intervention. Significant improvements on diagnostic status and reliable
change indexes were also found in both treatment groups at post-treatment. Regarding behavioral outcomes,
significant differences in safety behaviors were found at post-treatment, compared to the waiting list. Treatment
gains were maintained at 3- and 12-month follow-ups.
Conclusion: FP can be treated effectively via the Internet. NO-FEAR Airlines helps to enhance the exposure
technique and provide access to evidence-based psychological treatment to more people in need. These data are
congruent with previous studies highlighting the usefulness of computer-assisted exposure programs for FP, and
they contribute to the literature on Internet-based interventions. To the best of our knowledge, this is the first RCT
to investigate the effectiveness of an Internet-based treatment for FP and explore two ways of delivering the
intervention (with and without therapist guidance).
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Background
Flying phobia (FP) is a disabling disorder classified as a
specific situational phobia [1], although authors also
highlight its heterogeneous nature because FP symptoms
can be influenced by many other fears [2–4]. Up to 7%
of the population experience acute interference in daily
and social life functioning due to FP [5]. Furthermore,
around a quarter of the population (25%) suffer from
anxiety when taking a flight, approximately 20% depend
on alcohol or anxiolytics to fly, and about 10% avoid fly-
ing due to the intensity of their fear [6].
Research to date has pointed out that the most effect-
ive treatment approach for specific phobias (including
FP) is in vivo exposure, recommending it as the treat-
ment of choice [4, 7]. Specifically for FP, evidence indi-
cates that more than 90% of participants whose
treatment included in vivo exposure continued to fly at
one- to four-year follow-up [8]. Despite this evidence,
the in vivo exposure technique is linked to several limi-
tations in its implementation, such as low acceptance
among therapists and patients and difficulties in acces-
sing the treatment. Regarding acceptance, some authors
have considered in vivo exposure to be a cruel cure and
ethically inappropriate [9, 10]. Around 25% of patients
reject starting the treatment when they are informed
about the procedure, or they drop-out during treatment
because they consider it too aversive [11]. In terms of
accessibility, only 7.8% of people suffering from phobias
seek help [12], and very few of them (8%) receive a spe-
cific treatment for their problem [13]. In addition, in
vivo exposure involves lack of confidentiality and high
associated costs when conducted outside the therapist’s
office [14]. Two issues that are particularly important in
FP treatment are the economic cost of in vivo exposure
and the additional difficulty of applying the exposure
technique in an appropriate way (controlling important
variables such as the duration of the exposure or the
number of sessions) - due to the limited access to the
feared stimulus (i.e., airport or airplane) [15].
Therefore, there is a demand for better types of expos-
ure therapy. Specifically for FP, there is a need to im-
prove the adherence, acceptance, and accessibility of the
exposure therapy. Information and Communication
Technologies (ICTs) can be useful for overcoming these
issues, for example, through computerized treatments
such as virtual reality exposure therapy (VRET) and
computer-assisted exposure programs. The efficacy of
VRET has been shown in several meta-analyses and sys-
tematic reviews for the treatment of anxiety disorders
[16–19], including FP [6, 14, 20]. However, some authors
suggest that less sophisticated and cheaper devices might
be sufficient to produce satisfactory outcomes in FP
[21]. Thus, Tortella-Feliu et al. [22] showed that a
computer-assisted exposure program was as effective as
VRET in FP treatment. Moreover, no significant differ-
ences were found between two ways of delivering this
computer-assisted exposure treatment (with therapist as-
sistance throughout the exposure vs. self-administered in
the lab). According to these authors, the data also suggest
that therapist involvement might be minimized in FP
treatment using computer-assisted exposure programs.
An additional approach to using ICTs is to deliver psy-
chological treatments over the Internet. In the past decade,
the Internet has been established as a useful and effective
tool to treat several psychological disorders [23–25]. Par-
ticularly for anxiety disorders, Internet-based treatments
are highly effective and show comparable clinical out-
comes to face-to-face treatment and large effect sizes com-
pared to control groups (waiting list or placebo treatment)
[26–28]. Moreover, authors especially recommend the use
of self-applied interventions via the Internet for anxiety
disorders because of their numerous advantages, including
greater accessibility, versatility, safety, anonymity, accept-
ability, convenience, and cost-effectiveness [29–32].
Despite these findings and recommendations, research
on Internet-based treatments for specific phobias is still
scare. To date, the literature reviewed shows two ran-
domized controlled trials (RCT), one on spider phobia
[33] and one on snake phobia [34]. Similarly, Botella et
al. [35] showed preliminary data from a series of cases
about a self-applied telepsychology program using an
intranet to treat small animal phobia (spiders, cock-
roaches, and mice). Moreover, other studies have
pointed out the efficacy of Internet-based treatments for
several disorders, including specific phobia. One example
is the study by Kok, van Straten, Beekman and Cuijpers
[36] who examined the efficacy of an Internet-based ex-
posure intervention with weekly support for outpatients
waiting for face-to-face psychotherapy for several phobias.
In addition, several studies have tested the FearFighter™
program [37] for the treatment of panic and phobia disor-
ders [38–40], which is used in the mental health services
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in England [41]. Finally, from a transdiagnostic perspec-
tive, Schöder, Jelinek and Moritz [42] conducted a ran-
domized controlled trial of an Internet intervention for
individuals with panic and phobias.
Regarding studies designed for specific phobia treat-
ments, Andersson et al. [33, 34] found large
within-group effect sizes for self-administered Internet
treatments guided by the therapist from a distance,
although in both studies the one-session exposure treat-
ment (OST) was more effective than the self-
administered Internet interventions. Nevertheless, as the
authors noted, it is important to take into account that
the Internet treatments used in both studies consisted of
self-administered exposure, rather than a treatment de-
livered through a computer [34]. These treatments were
mainly provided in the form of downloadable pdf files
and a video sent to participants illustrating the exposure
principles. Internet-based treatments usually include
guidelines for exposure to the feared situations (i.e.,
downloadable pdf files), but without providing signifi-
cant exposure stimuli (i.e., self-administered exposure
scenarios through the computer). As some authors sug-
gest, this may be especially relevant in treating specific
phobias and other anxiety disorders [43, 44]. In line with
the recommendations made by Botella et al. [43], we
suggest that the combination of new technologies (i.e.,
multimedia exposure scenarios) and self-help procedures
could be a useful clinical tool for the treatment of other
psychological disorders, such as FP.
An important research issue in psychological treat-
ments delivered via the Internet is the impact of guid-
ance. Meta-analyses and systematic reviews have shown
the beneficial feature of providing guidance throughout
the intervention because it leads to better adherence and
outcomes [45–48]. Although the literature suggests that
the qualifications of those providing guidance (techni-
cians vs. clinicians) might be of minor importance [46],
some evidence highlights the superiority of guided inter-
ventions over unguided interventions [48]. Nevertheless,
authors have recently shown that the magnitude of these
differences is smaller than what was suggested in previ-
ous meta-analyses [46]. In addition, studies have pointed
out that self-guided interventions are useful alternatives
with similar outcomes that might work using automated
reinforcement and no human support [49–52]. Despite
these findings, there is no research on this issue in spe-
cific phobias, revealing the need for further research on
this topic, particularly in FP.
In sum, there is a growing body of evidence about the
effectiveness of Internet-based treatments to treat psycho-
logical disorders. However, the literature on specific pho-
bias is scarce in this regard, and few studies have focused
on the usefulness of the Internet in delivering systematic
exposure through the computer. To the best of our
knowledge, no published RCT has tested the efficacy of an
Internet-based exposure treatment for FP. Therefore, the
aim of this study is to investigate the effectiveness of an
Internet-based exposure treatment for FP (NO-FEAR Air-
lines) that includes exposure scenarios composed of im-
ages and real sounds, versus a waiting list control group,
in a randomized controlled trial (RCT). A secondary aim
is to explore two ways of delivering NO-FEAR Airlines,
with and without therapist guidance.
Methods
Study design
This study was a randomized controlled trial (RCT), in
which participants were randomly allocated to three
groups: 1) Internet-based exposure treatment for FP
without therapist guidance (NO-FEAR Airlines totally
self-applied, NFA); 2) Internet-based exposure treatment
for FP with therapist guidance (NO-FEAR Airlines with
therapist guidance, NFA + TG); and 3) a waiting list
(WL) control group. For ethical reasons, participants in
the WL group were randomly assigned to one of the two
treatment conditions after spending time on the waiting
list (6 weeks), thus leaving no control group for the
follow-up measurements. Therefore, 3- and 12-month
follow-up assessments were carried out for the two
intervention groups (NFA and NFA + TG). The trial was
registered at ClinicalTrials.gov (NCT02298478) on
November 3, 2014. This trial received approval from the
Ethics Committee of Universitat Jaume I (Castellón,
Spain) (20 December 2014) and was conducted in
compliance with the study protocol, following the
CONSORT statement (Consolidated Standards Of
Reporting Trials, http://www.consort-statement.org), the
CONSORT-EHEALTH guidelines [53], the APA guide-
lines for the practice of telepsychology [54], the Declar-
ation of Helsinki, and good clinical practice. Details of
the study protocol have been reported elsewhere [55].
Changes in the original protocol were made related to
the procedure for handling missing data. Intent-to-treat
(ITT) mixed-model analyses without any ad hoc imputa-
tions were conducted, rather than using analysis of vari-
ance (ANOVA) with multiple imputations (MI), based
on the authors’ recommendation and due to the large
amount of missing data at follow-up [56, 57]. Figure 1
shows the flow diagram.
Participants, recruitment and randomization
The study was advertised online via professional web-
sites (i.e., LinkedIn), non-professional social-networks
(i.e., Facebook and twitter), and announcements placed
in local universities and in the local media (newspapers
and radios). People who were interested in participating
in the study registered on the website [58] and signed
the informed consent form. The clinical team contacted
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participants by telephone or through the skype platform
in the case of international calls, in order to screen ac-
cessibility criteria and explain the terms of the research.
The inclusion criteria were: a) being at least 18 years old;
b) meeting DSM-5 criteria for specific, situational phobia
(FP) [1]; c) having adequate knowledge to understand
and read Spanish; d) having access to the Internet; e)
and ability to use a computer. The exclusion criteria
were: a) receiving psychological treatment for FP; b)
diagnosis of a severe mental disorder (abuse or depend-
ence on alcohol or other substances, psychotic disorder,
dementia, or bipolar disorder); c) presence of depressive
symptomatology, suicidal ideation or plan; d) presence
of heart disease; e) and pregnant women (from the
fourth month). Participants with comorbid and related
disorders (i.e., panic disorder, agoraphobia, claustropho-
bia, or acrophobia) were included when FP was the pri-
mary diagnosis. Receiving pharmacological treatment was
not an exclusion criterion, but any increase and/or change
in the medication during the study period implied the par-
ticipant’s exclusion from subsequent analyses. A decrease
in pharmacological treatment was accepted.
Participants who meet the criteria were administered a
baseline telephone assessment that included the diagnos-
tic interview. After that, they were randomly assigned to
one of the three experimental groups (n = 69). A
computer-generated randomization list was created
using the Epidat 4.0 program [59], by an independent re-
searcher who was unaware of the characteristics of the
study and had no clinical involvement in the trial or ac-
cess to the study data. The allocation scheme was com-
municated to clinicians via a phone call. In the same
way, researchers contacted participants to explain the
condition to which they had been allocated, and access
to the program was provided if required. Thus,
researchers and participants were blind to the
Fig. 1 Flowchart
Campos et al. BMC Psychiatry           (2019) 19:86 Page 4 of 16
experimental condition during the assessment at base-
line, and patients agreed to participate before knowing
the random allocation. However, they could not be blind
to the treatment conditions for practical reasons. Partici-
pants were free at any time to withdraw from the study
without giving any explanation. Access and participation
in the study did not involve payment in any case.
Intervention
NO-FEAR Airlines is a computer-aided exposure treatment
for FP that can be completely self-applied via the Internet
[55, 60] (see Additional file 1). This Internet-based inter-
vention allows people who are afraid of flying to be exposed
to images and real sounds related to their phobic fears on a
standard personal computer. The graphical user interface
was designed according to visual flying metaphors (i.e., Air-
line motifs) and with linear navigation, in order to optimize
the treatment structure and make the treatment easier and
more attractive to the users (Fig. 2). Based on this design,
the user can only continue on to the next section or take a
break and continue later from the same place.
The program includes both an assessment protocol
and a treatment protocol, which includes three thera-
peutic components (psychoeducation, exposure, and
overlearning), following the guidelines for good clin-
ical practice [1, 41]. First, psychoeducation includes
specific information related to FP (i.e., how many
people are affected, or how the problem begins and is
maintained), using text, vignettes, and illustrations.
Then, the exposure component is provided by the sys-
tem, depending on the patient’s anxiety level recorded
in the assessment (based on the FFQ-II questionnaire
scores [61]). Exposure is performed through six sce-
narios composed of significant stimuli such as images
and real sounds related to flying situations: (1) flight
preparation, (2) airport, (3) boarding and taking off,
(4) the central part of the flight, (5) the airplane’s
descent, approach to the runway, and landing, (6)
sequences with images and auditory stimuli related to
plane crashes. The system advances to the next
scenario when the user overcomes the current stage
(anxiety level below 3 on a scale ranging from 0 “no
anxiety” to 10 “high anxiety”). Thus, the program
reacts in real time to each patient’s needs on the
exposure task. After completing all the exposure
scenarios, overlearning is offered as additional
exposure, and participants may choose the scenarios
that they want to confront based on their needs -
from the same scenarios as in the exposure stage
(except the air crash news scenario) - with a higher
degree of difficulty, simulating storm conditions and
turbulence.
All participants were advised to participate in about
two exposure scenarios per week, taking a few days off
between sessions. It was estimated that the treatment
could be completed in three or four weeks, with a max-
imum period of six weeks. However, each participant
was free to advance at his/her own pace. Furthermore,
after the program, all the patients were encouraged to
take a real flight. Although it was recommended that the
flight be taken within two weeks after finishing the treat-
ment, participants could schedule it based on their
Fig. 2 NO-FEAR Airlines “screenshot”: Linear navigation design and Airline motif examples
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possibilities. The cost of the flight was paid for by each
participant. NO-FEAR Airlines provides guidelines to
cope with this test flight through downloadable material
(pdf files). At the end of the treatment, the system pro-
vides post-treatment and follow-up assessments.
The program described was implemented in two for-
mats: 1) NO-FEAR Airlines totally self-applied. Partici-
pants received the completely self-applied treatment and
only automatic support was provided throughout the
program (i.e., automatic reinforcement after each expos-
ure scenario). Technical assistance (i.e., web accessibility
problems or forgotten password) was provided, if neces-
sary. 2) NO-FEAR Airlines with therapist guidance. In
this case, participants also self-administered the treat-
ment via the Internet and received minimal telephone
support from the therapist. Therapist guidance consisted
of a brief weekly phone call (maximum 5min), to assess
and guide the participant’s progress by providing feed-
back and reinforcement until s/he had finished the treat-
ment. Thus, patients could receive up to 6 telephone
calls, and so they had a maximum of 30min of thera-
peutic support. In addition, the therapist checked for
any problems and reminded the participant about the
recommended treatment pace. Guidance content was
standardized; although it could be tailored depending on
patients’ needs (see Fig. 3 for details). However, support
calls could not include any additional clinical content.
Telephone guidance was provided by trained and experi-
enced psychologists.
Outcomes
Assessments were conducted via phone call, a commer-
cial online survey system (www.surveymonkey.com), and
the NO-FEAR Airlines program. Participants were
assessed at baseline, post-treatment, and 3- and
12-month follow-ups. A detailed description of the mea-
sures and sources of assessment can be found in the
study protocol [55]. Measures included in this study
were as follows:
Diagnostic interview. The Anxiety Disorders Interview
Schedule for DSM-IV-TR (ADIS-IV) [62]. Primary out-
comes. The Fear of Flying Questionnaire-II (FFQ-II)
[61]; The Fear of Flying scale (FFS) [63]. Secondary out-
comes. Fear and Avoidance Scales (adapted from Marks
& Mathews [64]); The Clinician Severity Scale (adapted
from Di Nardo, Brown & Barlow [65]); The Patient’s Im-
provement Scale (Adapted from the Clinical Global Im-
pression Scale [66]). Measures related to FP. The
duration of the problem; how many times the patient
has taken a flight; whether safety behaviors were used
(e.g., alcohol intake, distraction); and whether the par-
ticipant has had any negative experiences with flying.
Fig. 3 Therapist guidance protocol
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Sample size
Power calculations and Internet attrition rates (30%)
[67, 68] indicated that a sample size of a minimum of
57 participants (19 in each group) would be sufficient
to detect a large effect size (d = 1) with a power of 0.80
and an alpha of 0.05, based on a similar study [22] and
recent systematic reviews [32].
Statistical methods
Group differences in participants’ socio-demographic
and clinical data at baseline were examined using
one-way analyses of variance (ANOVAs) for continuous
data and chi-square tests (χ2) for categorical variables.
Intent-to-treat (ITT) mixed-model analyses without any
ad hoc imputations were conducted to handle missing
data due to participant drop-out [69]. This approach uses
all available data, it does not involve any substitution of
missing values with supposed or estimated values, and it
does not assume that the last measurement is stable (the
last observation carried forward assumption) [70, 71].
Mixed-model analyses are appropriate for RCTs with mul-
tiple time points and pre-to post-only designs [56]. The
assumption that data were missing completely at random
(MCAR) was evaluated using Little’s MCAR test. A linear
mixed-model for each outcome measure was imple-
mented using the MIXED procedure with one random
intercept per subject. An identity covariance structure was
specified to model the covariance structure of the random
intercept. For each outcome, time was treated as
within-group factor and group as a between-group factor.
Significant effects were followed up with pairwise compar-
isons (adjusted by Bonferroni correction). Separate
mixed-model analyses were conducted to compare
changes from baseline in each intervention, including both
the 3- and 12-month follow-ups. Effect sizes (Cohen’s d)
were calculated for within- and between-group compari-
sons [72–75]. The reliable change index (RCI) [76] for pri-
mary outcome measures (FFQ-II and FSS) was calculated
based on the completer sample at post-treatment.
Chi-square tests were performed to evaluate group differ-
ences in RCI rates, behavioral outcomes (post-treatment
flights and safety behaviors), and participant diagnostic
status for completers at post-treatment and two
follow-ups. All statistical analyses were conducted using
IBM SPSS Statistics for Windows, version 23.
Results
Participant flow and attrition
The recruitment started on September 2015 and
ended on August 2016. Initially, as the flow diagram
shows (Fig. 1), 146 people were interested in the study,
and 85 of them were assessed for eligibility criteria. At
this stage, 16 participants were excluded from the
study. Finally, 69 participants were included in the
study, and they were randomly allocated to each ex-
perimental condition (NO-FEAR Airlines totally
self-applied, n = 23; NO-FEAR Airlines with therapist
guidance, n = 23; and WL, n = 23). Of those who
started the program (n = 46), 13 participants (28.26%)
withdrew from the treatment conditions. No signifi-
cant differences were found between the two treat-
ment groups in attrition rates at post-treatment. At
3-month follow-up, a total of 22 participants (47.83%)
completed the assessment, with significant differences
between groups (χ2 (1) = 5.576; p = .018) (see Fig. 1
for details). Finally, at 12-month follow-up, a total of
20 participants completed the assessment (28.99%),
but no significant differences between groups were
obtained (χ2 (1) = 1.415; p = .234). The last participant
completed the 12-month follow-up in December
2017. In the WL control group, data from 23 partici-
pants were obtained after they had spent 6 weeks on
the waiting list (100% retention). Data were missing
completely at random (MCAR) (p > .05).
Baseline data and participant characteristics
Table 1 shows participants’ sociodemographic and clin-
ical data for each group. No statistically significant dif-
ferences were found on any sociodemographic or
participant’s data, or on primary and secondary out-
comes at baseline. Overall, participants came from
Spain (91.3%, n = 63), Colombia (2.9%, n = 2), Chile
(1.4%, n = 1), Cuba (1.4%, n = 1), USA (1.4%, n = 1),
and Italy (1.4%, n = 1). They were not receiving stable
medication, except four participants who were receiv-
ing anxiolytics to treat anxiety symptoms, with no
significant differences between groups. There were no
increases and/or changes in the medication intake
during the study.
Effectiveness: Change in primary and secondary
outcomes from pre- to post-treatment
Primary outcomes
The main effects of Time and Group were qualified by a
significant interaction for FFQ-II (F(2, 57.48) = 21.151; p
< .001) and FFS (F(2, 57.58) = 29.301; p < .001). For both
primary outcomes, within-group comparisons indicated
significant pre-to-post reductions in the two treatment
groups with large effect sizes, and non-significant changes
in the WL control group (see Table 2 for details).
Between-group comparisons revealed that participants
who received the treatment (with and without therapist
guidance) scored lower at post-treatment, compared to
the WL group, with large effect sizes (see Table 3). There
were no statistically significant differences between the
two treatment groups at post-treatment (all p > .05).
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Secondary outcomes
Regarding secondary outcome measures, the main ef-
fects of Time and Group were qualified by a significant
interaction for the Clinician Severity Scale (F(2, 62.13) =
34.867; p < .001) and the Fear and Avoidance Scales
related to the main target behavior (taking a flight) [Fear
(F(2, 64.54) = 17.906; p < .001), Avoidance (F(2, 57.52) =
21.242; p < .001), and the degree of Belief in the main
catastrophic thought (F(2, 60.14) = 24.771; p < .001)].
Results of within-group comparisons showed significant
reductions on these measures in the two treatment
groups, corresponding to large effect sizes (see Table 2).
There were no significant changes in the WL group,
except for Fear related to the target behavior (p < .05; d
= .84 [CI95% .50, 1.19]). At post-treatment, between-
group comparisons revealed that the two treatment
groups scored significantly lower on all the secondary
outcome measures, compared to WL, and non-
Table 1 Demographic and participant data
NFA
(n = 23)
NFA + TG
(n = 23)
WL
(n = 23)
Statistics
Age 36.30 (8.14)
[range = 21–50]
38.87 (13.56)
[range = 20–65]
34.13 (9.00)
[range = 21–53]
F(2,69) = 1.173
p = .316
Sex
Male 8 (34.8%) 6 (26.1%) 5 (21.7%) χ2(2) = 1.02
p = .601
Female 15 (65.2%) 17 (73.9%) 18 (78.3%)
Marital status
Married 12 (52.2%) 11 (47.8%) 10 (43.5%) χ2 (4) = .74
p = .946
Single 10 (43.5%) 11 (47.8%) 11 (47.8%)
Divorced/Separated 1 (4.3%) 1 (4.3%) 2 (8.7%)
Educational status
Primary studies – – 1 (4.3%) χ2(4) = 5.49
p = .240
Secondary school 2 (8.7%) 7 (30.4%) 5 (21.7%)
University education 21 (91.3%) 16 (69.6%) 17 (73.9%)
Employment status
Student 4 (17.4%) 4 (17.4%) 1 (4.3%) χ2(8) = 12.41
p = .134
Unemployed 4 (17.4%) 4 (17.4%) 1 (4.3%)
Employed 15 (65.2%) 12 (52.2%) 2 (8.7%)
Retired – 3 (13%) 19 (82.6%)
Medication
Yes 1 (4.3%) 2 (8.7%) 1 (4.3%) χ2(2) = .53
p = .767
No 22 (95.7%) 21 (91.3%) 22 (95.7%)
Experience Flying?
Yes 21 (91.3%) 20 (87%) 22 (95.6%) χ2(2) = 1.20
No 2 (8.7%) 3 (13%) 1 (4.4%) p = .547
Duration of Phobia
< 6 months 1 (4.3%) 1 (4.4%) 1 (4.4%) χ2(8) = 2.145
6–12 months 0 (0%) 1 (4.4%) 1 (4.4%) p = .976
1–5 years 3 (13%) 3 (13%) 3 (13%)
6–10 years 7 (30.4%) 7 (30.4%) 7 (30.4%)
> 11 years 12 (52.2%) 11 (47.8%) 11 (47.8%)
Nationality
Spanish 21 20 22 χ2(2) = 1.09
p = .578
Foreign 2 3 1
Means and standard deviations (SD) are represented for age (years). NFA. NO-FEAR Airlines totally self-applied without therapist guidance. NFA + TG. NO-FEAR
Airlines with Therapist guidance. WL. Waiting list
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significant differences were found between the two ways
of delivering the Internet-based treatment (with and
without therapist guidance) (Table 3).
For the Patient’s Improvement Scale assessed at
post-treatment, results showed a significant main effect
of Group (F(2, 52) = 20.807; p < .001), indicating that the
improvement achieved and reported by patients was sta-
tistically higher in the Internet-based treatment groups
(with and without therapist guidance) compared to WL
with large effect sizes (Table 3). The differences between
the two treatment groups were not statistically signifi-
cant (all p > .05).
Maintenance of treatment gains at 3- and 12-month
follow-ups
Separate linear mixed-model analyses yielded a signifi-
cant main effect of Time on all the primary and second-
ary outcomes (all ps < .001), except for the Patient’s
improvement Scale. Overall, within-group comparisons
revealed significant changes from baseline to the 3- and
12-month follow-ups in the two treatment groups, indi-
cating maintenance of the treatment gains. In addition,
taken together, within-group effect sizes were higher for
the pre-treatment to 3- and 12-month follow-up changes
than for the pre- to post-treatment change (see Table 3).
Table 3 Between-group comparisons and effect sizes on primary and secondary outcome measures at post-treatment and 3- and
12-month follow-up
Post-treatment 3-month follow-up 12-month follow up
Mean dif. d (95%CI) Mean dif. d (95%CI) Mean dif. d (95%CI)
FFQ-II
NFA vs. WL −57.78*** d = −1.13 (−1.81, −.46) – –
NFA + TG vs. WL −66.45*** d = − 1.27 (− 1.98, −.56) – –
NFA vs. NFA + TG 8.67 d = .23 (−.46, .93) −.25 d = .15 (−.77, 1.07) 36.90 .68 (−.24, 1.60)
FFS
NFA vs. WL − 17.23*** d = − 1.51 (−.2.13, −.71) – –
NFA + TG vs. WL −17.68*** d = − 1.21 (− 1.92, −.49) – –
NFA vs. NFA + TG .46 d = .03 (−.66, .73) −.53 d = .04 (−.86, .94) 9.11 .74 (−.18, 1.66)
TB
Fear NFA vs. WL −.2.86*** d = − 1.40 (−2.10, −.69) – –
NFA + TG vs. WL −3.06*** d = − 1.25 (− 1.96, −.54) – –
NFA vs. NFA + TG .21 d = .08 (−.06, .78) 1.08 d = .34 (−.01, .68) 1.77* .74 (−.16, 1.66)
Avoidance
NFA vs. WL −3.83*** d = − 1.48 (− 2.19, −.76) – –
NFA + TG vs. WL −3.83*** d = − 1.21 (− 1.91, −.51) – –
NFA vs. NFA + TG .004 d = −.02 (−.71, .66) .66 d = .35 (−.55, 1.25) 1.70 .66 (−.26, 1.57)
Belief
NFA vs. WL −3.42*** d = − 1.79 (− 2.54, − 1.04) – –
NFA + TG vs. WL −3.95*** d = − 1.80 (− 2.56, − 1.04) – –
NFA vs. NFA + TG .53 d = .19 (−.49, .87) 1.08 d = .48 (−.43, 1.40) 2.90* 1.14 (.18, 2.11)
Severity
NFA vs. WL −3.07*** d = − 2.25 (− 3.10, − 1.45) – –
NFA + TG vs. WL −3.11*** d = − 1.69 (− 2.44, −.94) – –
NFA vs. NFA + TG .04 d = −.01 (−.69, .68) .42 d = .36 (−.54, 1.39) 1.173 .63 (−.28, 1.55)
Improvement
NFA vs. WL 1.50*** d = 2.00 (1.23, 2.46) – –
NFA + TG vs. WL 1.53*** d = 1.71 (.96, 2.46) – –
NFA vs. NFA + TG −.26 d = −.03 (−.71, .65) − 1.64 d = −.51 (− 1.42, .40) −.58 −.65 (− 1.56, .27)
NFA NO-FEAR Airlines totally self-applied without therapist guidance NFA + TG NO-FEAR Airlines with Therapist guidance, Mean dif Mean differences, WL Waiting
list, d. Cohen’s d. CI Confidence interval, FFQ-II Fear of Flying questionnaire, FFS Fear of Flying Scale, TB Target Behavior Belief. Degree of belief on the main
irrational thought related to the target behavior. Severity. The Clinician Severity Scale. Improvement. The Patient’s Improvement Scale
* p < .05. *** p < .001
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No significant interaction effect (Time by Group) was
found on primary and secondary measures, except for
the degree of Belief in the main catastrophic thought re-
lated to the main target behavior (taking a flight) (F(2,
87.03) = 2.868; p < .001), indicating that the Internet-
based treatment with therapist guidance group scored
lower than the completely self-applied group at
12-month follow-up (d = 1.14; 95% IC (.18, 2.11)). Separ-
ate between-group comparisons also revealed significant
differences between the two Internet-based treatment
groups (with and without therapist guidance) at
12-month follow-up on Fear related to the main target
behavior, showing lower fear scores in the NO-FEAR
Airlines with therapist guidance group (Table 3). No
other significant between-group differences were found
at 3- and 12-month follow-ups.
Clinically meaningful improvement: Reliable change
Figure 4 presents the proportion of completers in each
condition who were recovered, improved, unimproved,
or deteriorated at post-treatment. At post-treatment, sta-
tistically significant differences were found between the
three conditions in these percentages on the FFQ-II
(χ2(2) = 9.82; p < .01) and the FSS (χ2(4) = 31.972; p
< .001). Overall, participants who had received the
Internet-based interventions (with and without therapist
guidance) showed higher recovered percentage com-
pared to WL.
Diagnostic status and behavioral outcomes
Results for diagnostic status and behavioral outcome
measures (post-treatment flights and safety behaviors)
are shown in Table 4. Analyses revealed statistically sig-
nificant differences between groups at post-treatment for
FP diagnostic status, safety behaviors, and number of
safety behaviors. Specifically, both treatment groups
(with and without therapist guidance) scored lower than
the WL group: they had a lower percentage of FP diag-
nosis, the number of participants who reported using
safety behaviors was lower, and they used fewer safety
behaviors. No statistically significant differences were
found at 3- and 12-month follow-ups on diagnostic sta-
tus or the behavioral outcome measures.
Discussion
The aim of this study was to investigate the effectiveness
of an Internet-based exposure treatment for FP
(NO-FEAR Airlines) compared to a WL control group in
an RCT. Overall, the data revealed that the self-applied
online intervention (with and without therapist guid-
ance) was effective in treating FP, compared to the WL,
with large between-group effect sizes at post-treatment.
Results showed a statistically significant change from pre
to post treatment on all primary and secondary outcome
measures, corresponding to large within-group effect
sizes in both Internet-based treatment groups. Regarding
the diagnostic status and reliable change indexes, signifi-
cant improvements were found in the two treatment
groups compared to the WL. In addition, these treat-
ment gains were maintained at 3- and 12-month
follow-ups, and overall effect sizes were larger than
those obtained for the pre-to-post change. These find-
ings are consistent with previous studies showing the ef-
ficacy of computer-assisted exposure programs for FP
treatment [21, 22].
An important research issue addressed in this study
involves the use of the Internet to deliver self-
administered exposure to the feared stimuli. NO-FEAR
Airlines includes self-administered exposure scenarios
composed of images and real sounds to provide system-
atic exposure through the computer. Therefore, results
from the present study show that the combination of
new technologies and self-help procedures is a useful
clinical tool for FP treatment, as authors have also found
for fear of public speaking [43]. It is also worth
highlighting that, in addition to being effective,
NO-FEAR Airlines seems to be well accepted by partici-
pants because none of the participants refused to start
the treatment when they were informed about the pro-
cedure. This fact is especially relevant because it might
Fig. 4 Reliable change. Percentage of the completer sample in each condition corresponding to recovered, improved, unimproved or
deteriorated. FFQ-II. Fear of Flying Questionnaire. FFS. Fear of Flying Scale. NFA. NO-FEAR Airlines. NFA + TG. NO-FEAR Airlines with therapist
guidance. WL. Waiting list
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suggest that Internet-based exposure treatment is a use-
ful alternative to in vivo exposure, providing a less
frightening way for participants to confront their fears
[44]. As stated above, to date, most of the Internet-based
treatments that include the exposure technique provide
guidelines to face the feared stimuli through download-
able pdf files rather than through multimedia exposure
scenarios. Given these findings, along with the recent
advances and growing technological developments, fur-
ther research is needed to improve Internet-based treat-
ments that include exposure among their treatment
components.
A secondary aim of this study was to explore the im-
pact of therapist guidance. Our results overall indicate
that providing a weekly phone call from a therapist did
not significantly affect treatment outcomes at
post-treatment or 3- and 12-month follow-ups. These
findings are congruent with studies suggesting that ther-
apist involvement might be minimized for FP treatment
using computer-assisted exposure programs [22], and
they contradict other findings showing the superiority of
guided interventions over unguided interventions [48].
In this regard, it is important to note some issues that
could explain our results. First, NO-FEAR Airlines was
designed with linear navigation to make the treatment
easier and ensure that participants only continue on to
the next section (or exposure scenario) when they are
ready. Moreover, after participants had overcome each
exposure scenario, automated reminders and reinforce-
ments were provided through text displayed on the
screen. As various authors suggested, if the self-applied
program is well structured and designed, and automated
support is provided throughout the intervention, the role of
human guidance might be less important [49–51, 77–79].
Second, all the participants received an initial phone call
from a therapist who explained the research and conducted
the screening procedures and telephone interviews. Re-
search has highlighted that providing brief initial human
contact before starting the treatment might be sufficient to
produce an effect on the treatment outcomes, reducing the
need for or impact of guidance throughout the treatment
[80]. Third, therapist guidance might have different impli-
cations depending on the disorder addressed. Thus, it is
also necessary to consider studies indicating that, whereas
self-help interventions without therapist contact can be
useful to treat simple psychological disorders (i.e., specific
phobias), they may be insufficient for more severe mental
disorders [43, 81]. Although there is recent evidence show-
ing the utility of self-guided Internet Interventions for se-
vere disorders (i.e., depression) [50], this issue remains
unclear. Moreover, and despite our findings, research fo-
cusing on specific phobia treatment is scarce. There are
only two RCT on Internet-based treatments but both in-
volve direct self-exposure guided by the therapist from a
Table 4 Diagnostic status and behavioral outcome measures at post-treatment and 3-and 12-month follow-up
NFA NFA + TG WL Statistics
Post
(n = 17)
3FW
(n = 15)
12FW
(n = 12)
Post
(n = 15)
3FW
(n = 7)
12FW
(n = 8)
Post
(n = 23)
FP Diagnosis Yes 11 6 6 9 3 1 23 Post: χ2(2) =10.709; p < .01
No 6 9 6 6 4 7 0 3FW: χ2(1) = .175; p = .676
12FW: χ2(1) = 2.967; p = .085
Post-treatment flights Yes 5 12 10 3 3 6 3 Post: χ2(2) = 1.514; p = .469
No 12 3 2 12 4 2 20 3FW: χ2(1) = 1.257; p = .262
12FW: χ2(1) = 1.257; p = .648
Number of flights taken 0 12 3 2 12 3 0 20 Post: χ2(6) = 3.059; p = .801
2 4 9 5 3 2 3 0 3FW: χ2(4) = 3.101; p = .541
4 1 2 2 0 2 3 2 12FW: χ2 (4) = 3.718; p = .446
6 0 1 3* 0 0 2* 1
Safety behaviors Yes 2 7 5 1 2 4 18 Post: χ2 (2) = 25.408; p < .01
No 15 8 7 14 5 4 5 3FW: χ2 (1) = 1.174; p = .279
12FW: χ2 (1) = .038; p = .845
Number of safety behaviors 0 15 7 7 14 5 4 1 Post: χ2 (14) = 41.357; p < .001
1–3 2 6 4 1 1 3 16 3FW: χ2 (4) = 4.982; p = .289
4–6 0 0 1 0 1 1 5 12FW: χ2 (4) = .950; p = .917
7–9 0 0 0 0 0 1
NFA. NO-FEAR Airlines totally self-applied. NFA + TG. NO-FEAR Airlines with therapist guidance. FP. Flying Phobia. Post. Post-treatment. 3FW. 3-month follow-up.
12FW. 12-month follow-up.
*from 6 to 12 flights taken
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distance, without addressing this topic [33, 34]. Fourth,
therapist guidance may have significant effects in the long
term instead of the short term, and therefore longer assess-
ments are needed to reveal its effects. In our study, al-
though generally there was no significant effect of therapist
guidance on outcomes at post-treatment or 3- and
12-month follow-ups, a significantly lower belief in the
main catastrophic thought and lower fear related to the
main target behavior (taking a flight) were found in the
supported group (NO-FEAR Airlines with therapist guid-
ance) at 12-month follow-up. This result indicates that pro-
viding weekly therapist guidance through a brief phone call
(i.e., 5 min) throughout the online intervention may help to
reduce both the fear level and the degree of belief in cata-
strophic thoughts in the long term. However, more re-
search is needed to continue to explore the impact of
guidance, including long-term assessments. Furthermore,
the therapist guidance that consisted of a brief weekly
phone call of 5min as maximum to provide feedback and
reinforcement may be too short in order to achieve signifi-
cant differences between the two interventions groups in-
cluded in the present study (with or without therapist
guidance). As far as we know, few studies have formally ad-
dressed the impact of dose–response-relationship regarding
guidance on Internet interventions. As Baumeister et al.
[46] pointed out in their systematic review study, only one
study compared higher dose of guidance versus lower dose
of guidance finding no statistically significant differences on
symptoms severity at post-treatment. However, this study
focused on the dose of guidance provided by email (one or
three emails per week) and not on the guidance duration
(i.e., minutes of the phone call).
In summary, our results point out the efficacy of
NO-FEAR Airlines with and without therapist guidance.
However, there are some limitations that should be men-
tioned. First, assessments were conducted online and via
phone calls. Although several studies have shown the use-
fulness of Internet and telephone administered assessments
[82–84], some authors suggest that psychometric properties
may change [85]. Second, missing data at two follow-up
assessments (3 and 12months) were higher than expected
(> 30%). Even though NO-FEAR Airlines sent automated
reminders to participants and researchers to complete the
assessment, we were unable to contact many of them, and
they did not complete the 3- and 12-month follow-ups,
limiting our conclusions about long-term treatment gains.
Third, the interpretation of the behavioral outcome mea-
sures was compromised due to the low number of partici-
pants taking a flight after the treatment and the missing
data rates, mentioned above. Given the importance of tak-
ing a flight after the treatment, outlined in several studies
[8, 14, 86], further efforts are needed in this regard. We
suggest that the use of persuasive technologies [78] to pro-
vide guidance and reinforcement after the treatment, as
well as the use of short intervention packages (via web or
mobile) to review or practice before taking a flight, could
be useful in this endeavor. Despite that ADIS-IV was used
as diagnosis interview and exclusion criteria were assessed
in the screening conducted by telephone and throughout
the protocol assessment included in NO-FEAR Airlines, no
other diagnostic interview was systematically used to for-
mally assess the presence of other mental disorder different
from anxiety disorders. Finally, the study design and sample
size calculations were mainly conducted as a superiority
trial rather than as an equivalence trial [87–89]. Therefore,
we can state that both ways of delivering the treatment
(with and without therapist guidance) were effective for the
treatment of FP, compared to the WL, but we cannot con-
clude that both conditions were equally efficacious. Future
studies should be carried out to formally assess these
issues.
As far as we know, this is the first RCT to investigate
the effectiveness of an Internet-based intervention for
FP and explore two ways of delivering the treatment
(with and without therapist guidance). Overall, our find-
ings indicate that FP can be effectively treated via the
Internet. This study contributes to the literature on
Internet-based interventions and adds additional data to
the research on the use of computer-assisted exposure
programs for FP treatment.
Conclusions
The Internet-based treatment (NO-FEAR Airlines) was
effective for treating FP, compared to a WL, regardless
of whether therapist guidance was provided or not.
NO-FEAR Airlines includes significant self-administered
exposure scenarios composed of images and real sounds
to enhance the exposure technique for FP treatment.
This program helps to improve access to evidence-based
psychological treatment and reach more people who
may need it.
Additional file
Additional file 1: NO-FEAR Airlines. Video about NO-FEAR Airlines, an
Internet-based Exposure treatment for Flying Phobia. The video includes
a description about the online program, how it works and on how it has
been assessed in an RCT. (MP4 58734 kb)
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